Chemical Structure (Gabapentin 01)
Chemical structure diagram of gabapentin showing its cyclohexane ring with attached amino and carboxymethyl groups.*
Gabapentin Tablet, Coated
Product Images NDC 69367-346
7 FDA label images from Westminster Pharmaceuticals, Llc · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 69367-346). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Westminster Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Gabapentin 02)
A line graph showing mean pain score over an 8-week period comparing placebo and Gabapentin 3,600 mg/day. The x-axis represents weeks, starting from baseline through week 8, with labeled 4-week dose titration and 4-week fixed dose periods. The y-axis shows mean pain scores from 0 to 10. Gabapentin group shows a decreasing pain score over time, while placebo remains relatively stable.*
Figure 2 (Gabapentin 03)
Line graph depicting the mean pain score over a 7-week period, including a 3-week dose titration and a 4-week fixed dose period. The graph compares placebo with Gabapentin at 1,800 mg/day and 2,400 mg/day doses, showing trends in pain score reduction over time.*
Figure 3 (Gabapentin 04)
A bar chart comparing the effects of placebo (PBO) versus gabapentin (GBP) at different doses in two studies. Study 1 shows 12% for PBO and 29% for GBP 3,600 mg. Study 2 shows 14% for PBO, 32% for GBP 1,800 mg, and 34% for GBP 2,400 mg. Statistical significance is indicated with p-values less than 0.01 and 0.001.*
Figure 4 (Gabapentin 05)
A chart comparing percentage differences across three studies labeled 'STUDY a,' 'STUDY b,' and 'STUDY c' plotted against daily doses in milligrams (600, 900, 1200, 1800 mg). The vertical axis represents the percentage difference from 2% to 22%, with data points for each study at various dose levels.*
Principal Display Panel (600 mg Tablet Bottle Label)
Label for Gabapentin Tablets, USP, coated oral tablets with a strength of 600 mg. The package contains 500 tablets. The label includes storage instructions, dosage guidance, and manufacturer details: Manufactured by CSPC Ouyi Pharmaceutical Co., Ltd. in China and labeled for Westminster Pharmaceuticals, LLC, Nashville, TN.*
Principal Display Panel (800 mg Tablet Bottle Label)
Label for Gabapentin Tablets, USP 800 mg coated tablets, oral use, in a package of 500 tablets. The label indicates it is manufactured by CSPC Ouyi Pharmaceutical Co., Ltd and marketed by Westminster Pharmaceuticals, LLC. Storage instructions specify 25°C with permitted excursions. The label includes a barcode and a website for medication guides.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
